Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2006 1
2007 3
2008 1
2010 2
2011 3
2012 1
2013 1
2015 2
2016 4
2017 3
2018 1
2020 3
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization.
Jiménez-Cortegana C, Salamanca E, Palazón-Carrión N, Sánchez-Jiménez F, Pérez-Pérez A, Vilariño-García T, Fuentes S, Martín S, Jiménez M, Galván R, Rodríguez-Chacón C, Sánchez-Mora C, Moreno-Mellado E, Gutiérrez-Gutiérrez B, Álvarez N, Sosa A, Garnacho-Montero J, de la Cruz-Merino L, Rodríguez-Baño J, Sánchez-Margalet V. Jiménez-Cortegana C, et al. Among authors: fuentes s. Front Immunol. 2023 Nov 14;14:1266659. doi: 10.3389/fimmu.2023.1266659. eCollection 2023. Front Immunol. 2023. PMID: 38035104 Free PMC article.
Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19.
Jiménez-Cortegana C, Sánchez-Jiménez F, Pérez-Pérez A, Álvarez N, Sousa A, Cantón-Bulnes L, Vilariño-García T, Fuentes S, Martín S, Jiménez M, León-Justel A, de la Cruz-Merino L, Garnacho-Montero J, Sánchez-Margalet V. Jiménez-Cortegana C, et al. Among authors: fuentes s. Front Immunol. 2022 Jan 28;12:801410. doi: 10.3389/fimmu.2021.801410. eCollection 2021. Front Immunol. 2022. PMID: 35154077 Free PMC article.
Development and validation of a laboratory-based risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19.
Martin S, Fuentes S, Sanchez C, Jimenez M, Navarro C, Perez H, Salamanca E, Santotoribio JD, Bobillo J, Giron JA, Gonzalez J, Garrido JM, Liro J, Guerrero JM, Sanchez-Pozo MC, Sanchez-Margalet V, Leon-Justel A. Martin S, et al. Among authors: fuentes s. Scand J Clin Lab Invest. 2021 Jul;81(4):282-289. doi: 10.1080/00365513.2020.1847313. Epub 2021 May 11. Scand J Clin Lab Invest. 2021. PMID: 33974458
26 results